Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection

[Display omitted] •The risk of HBV reactivation for patients with lymphoma and resolved HBV infection varied.•High anti-HBc and low anti-HBs at baseline predicted high risk of HBV reactivation.•Quantification of baseline anti-HBc/anti-HBs may optimize preventive strategies. Absence or low anti-HBV s...

Ausführliche Beschreibung